TRAVERE THERAPEUTICS, INC. (TVTX) Revenue 2016–2025
TRAVERE THERAPEUTICS, INC. (TVTX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$490.7MFY2025 · since FY2016: $133.6M → $490.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $490.7M | +110.5% |
| FY2024 | $233.2M | +60.5% |
| FY2023 | $145.2M | +32.7% |
| FY2022 | $109.5M | -17.0% |
| FY2021 | $131.8M | -33.5% |
| FY2020 | $198.3M | +13.1% |
| FY2019 | $175.3M | +6.8% |
| FY2018 | $164.2M | +6.0% |
| FY2017 | $154.9M | +16.0% |
| FY2016 | $133.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice